Rapid Communication – SAH pathophysiology
Previous medical history as a risk factor for intracranial aneurysms formation
The course and value of interleukin-6 in cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage
Association of biomarkers of NETosis with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage
Evaluation of neurodegenerative CSF markers in sex- and age-matched cohorts with and without aneurysmal subarachnoid hemorrhage
Cerebrovascular manipulation induces an excessive release of endogenous neuropeptide Y into serum
Serum concentration guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: Retrospective evaluation of a 12-year single center experience
Recovery of pathophysiological alterations in cerebral energy metabolism after aneurysmal subarachnoid hemorrhage: A prospective 31P-MR-spectroscopy follow-up study
Systemic Administration of Argatroban Reduces Secondary Brain Damage in a Mouse Model of Intracerebral Hemorrhage
19F Magnetic Resonance Imaging in Experimental Subarachnoid Hemorrhage
Extracellular RNA drives the immune cell activation after experimental subarachnoid hemorrhage
The effect of human CSF on gene expression in cardiomyocytes - analyzing brain-heart interactions in subarachnoid hemorrhage in an in vitro system
The association between aneurysmal subarachnoid hemorrhage and vitamin D serum levels – an analysis of the UK Biobank